Press releases
Press releases
Here we list English translations of the Swedish press releases published by Neola Medical AB (publ). For official press releases, please visit our Swedish website.
Neola Medical invites to presentation of the Q3-report 2023
Press communication Lund, Sweden, November 2nd, 2023 This is a translation of the Swedish press release published 2023-11-02 Neola Medical AB (publ) invites to presentation of the Q3-report of 2023, Thursday the 9th of November 2023 at 9am CET (09.00). The...
Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1
Press communication Lund, Sweden, October 12, 2023 This is a translation of the Swedish press release published 2023-10-12 Neola Medical is one of the few companies that have been selected to receive support from the Stanford University (Stanford) Impact1 program....
New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device
Press communication Lund, Sweden, October 10, 2023 This is a translation of the Swedish press release published 2023-10-09 At the jENS conference in Italy on September 23, 2023, the clinical researcher and neonatologist Jurate Panaviene presented new results and...
Neola Medical AB appoints ABG Sundal Collier as liquidity provider
Press communication Lund, Sweden, August 17, 2023 This is a translation of the Swedish press release published 2023-08-17 Neola Medical AB (the “Company”) has appointed ABG Sundal Collier (“ABGSC”) as liquidity provider for the Company’s shares listed on Nasdaq...
Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.
This is a translation of the Swedish press release published 2023-08-15, 08.00 CEST Neola Medical AB (publ) today publishes the Q2 report of 2023 (in Swedish). The report is available at the company's website and is attached to the press release. During the...
Neola Medicals trademark has been registered in the U.S.
Press communication Lund, Sweden, August 8, 2023 This is a translation of the Swedish press release published 2023-08-08 Neola Medical AB (publ) announces today that the company’s trademark, Neola®, has been registered in the U.S, the company’s most important...
Neola Medical invites to presentation of the Q2-report 2023
This is a translation of the Swedish press release published 2023-08-07 Neola Medical AB (publ) invites to presentation of the Q2-report of 2023, Tuesday August 15, 2023, at 11am (CET, 11.00). The presentation will be held online as a video conference. The...
Neola Medical’s CEO tells more about the latest news in the investor letter for summer 2023
This is a translation of the Swedish press release published 2023-07-10 The market preparations before the launch continues with regulatory processes, visits to the PAS-conference in Washington, increased protection for Neola® through a new U.S. patent and...
Neola Medical initiates market preparation work in the U.S. with an office in Palo Alto, Silicon Valley
Press communication Lund, Sweden, June 14, 2023 This is a translation of the Swedish press release published 2023-06-14 Neola Medical AB (publ) announces today that the company, in addition to its headquarters in Lund, will increase the presence in the U.S. by an...
Neola Medical Q1 report 2023 – The market preparations initiated and Vinnova-grant received
This is a translation of the Swedish press release published 2023-05-17, 08.00 CET Neola Medical AB (publ) today publishes the Q1 report of 2023 (in Swedish). The report is available at the company's website and is attached to the press release. Attendance at the...
